Giant cell tumour of the distal radius/ulna: Response to pre-operative treatment with short-term denosumab

<h4>Background</h4> <p>Treatment of giant cell tumour of bone (GCTB) of the distal radius/ulna poses a surgical challenge, as complex reconstructive surgery may be required. This study evaluates the clinical, radiological and pathological findings in five cases of GCTB of the dist...

Full description

Bibliographic Details
Main Authors: McCarthy, C, Gibbons, C, Bradley, K, Hassan, A, Giele, H, Athanasou, N
Format: Journal article
Language:English
Published: BioMed Central 2017
_version_ 1797082715232665600
author McCarthy, C
Gibbons, C
Bradley, K
Hassan, A
Giele, H
Athanasou, N
author_facet McCarthy, C
Gibbons, C
Bradley, K
Hassan, A
Giele, H
Athanasou, N
author_sort McCarthy, C
collection OXFORD
description <h4>Background</h4> <p>Treatment of giant cell tumour of bone (GCTB) of the distal radius/ulna poses a surgical challenge, as complex reconstructive surgery may be required. This study evaluates the clinical, radiological and pathological findings in five cases of GCTB of the distal forearm where a 3 month course of denosumab was given prior to surgery.</p> <h4>Methods</h4> <p>Patients with biopsy proven distal forearm GCTB, treated for 3 months with denosumab, followed by salvage surgery (curettage and cementation) were included. Wrist pain and function were assessed using the modified Mayo Wrist Score (MMWS). Plain radiographs, MRI and PET/CT were performed pre-treatment and 2 months after initiation of denosumab therapy. Histological comparison was made between the original biopsy and surgical curettage specimens.</p> <h4>Results</h4> <p>Five patients with an average age of 25 years were included in the study. Improvement in wrist pain and function was seen in all patients with the average MMWS increasing from 30 pre-treatment to 85 at 3 months. Plain radiographs demonstrated marginal sclerosis in all cases with reconstitution of cortical and subarticular bone by 2 months; internal matrix sclerosis and osseous consolidation was more variable. Increased tumour heterogeneity and low signal were observed on T2-weighted MR images. PET/CT revealed a decrease in average SUV from 14.8 pre-treatment to 4.7 at 2 months. Histology showed disappearance of osteoclasts and increased fibro-osseous tissue. Denosumab treatment has the potential to facilitate salvage surgery, thus avoiding bone resection and graft reconstruction. A good outcome was achieved apart from local recurrence in one case. Follow up ranged from 17 to 54 months.</p> <h4>Conclusion</h4> <p>Distal forearm GCTB responds clinically, radiologically and histologically to a short course of pre-operative denosumab therapy, which has the potential to facilitate salvage surgery.</p>
first_indexed 2024-03-07T01:31:44Z
format Journal article
id oxford-uuid:93d41025-88d2-46ce-a442-adc8fdcf1af7
institution University of Oxford
language English
last_indexed 2024-03-07T01:31:44Z
publishDate 2017
publisher BioMed Central
record_format dspace
spelling oxford-uuid:93d41025-88d2-46ce-a442-adc8fdcf1af72022-03-26T23:34:58ZGiant cell tumour of the distal radius/ulna: Response to pre-operative treatment with short-term denosumabJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:93d41025-88d2-46ce-a442-adc8fdcf1af7EnglishSymplectic Elements at OxfordBioMed Central2017McCarthy, CGibbons, CBradley, KHassan, AGiele, HAthanasou, N <h4>Background</h4> <p>Treatment of giant cell tumour of bone (GCTB) of the distal radius/ulna poses a surgical challenge, as complex reconstructive surgery may be required. This study evaluates the clinical, radiological and pathological findings in five cases of GCTB of the distal forearm where a 3 month course of denosumab was given prior to surgery.</p> <h4>Methods</h4> <p>Patients with biopsy proven distal forearm GCTB, treated for 3 months with denosumab, followed by salvage surgery (curettage and cementation) were included. Wrist pain and function were assessed using the modified Mayo Wrist Score (MMWS). Plain radiographs, MRI and PET/CT were performed pre-treatment and 2 months after initiation of denosumab therapy. Histological comparison was made between the original biopsy and surgical curettage specimens.</p> <h4>Results</h4> <p>Five patients with an average age of 25 years were included in the study. Improvement in wrist pain and function was seen in all patients with the average MMWS increasing from 30 pre-treatment to 85 at 3 months. Plain radiographs demonstrated marginal sclerosis in all cases with reconstitution of cortical and subarticular bone by 2 months; internal matrix sclerosis and osseous consolidation was more variable. Increased tumour heterogeneity and low signal were observed on T2-weighted MR images. PET/CT revealed a decrease in average SUV from 14.8 pre-treatment to 4.7 at 2 months. Histology showed disappearance of osteoclasts and increased fibro-osseous tissue. Denosumab treatment has the potential to facilitate salvage surgery, thus avoiding bone resection and graft reconstruction. A good outcome was achieved apart from local recurrence in one case. Follow up ranged from 17 to 54 months.</p> <h4>Conclusion</h4> <p>Distal forearm GCTB responds clinically, radiologically and histologically to a short course of pre-operative denosumab therapy, which has the potential to facilitate salvage surgery.</p>
spellingShingle McCarthy, C
Gibbons, C
Bradley, K
Hassan, A
Giele, H
Athanasou, N
Giant cell tumour of the distal radius/ulna: Response to pre-operative treatment with short-term denosumab
title Giant cell tumour of the distal radius/ulna: Response to pre-operative treatment with short-term denosumab
title_full Giant cell tumour of the distal radius/ulna: Response to pre-operative treatment with short-term denosumab
title_fullStr Giant cell tumour of the distal radius/ulna: Response to pre-operative treatment with short-term denosumab
title_full_unstemmed Giant cell tumour of the distal radius/ulna: Response to pre-operative treatment with short-term denosumab
title_short Giant cell tumour of the distal radius/ulna: Response to pre-operative treatment with short-term denosumab
title_sort giant cell tumour of the distal radius ulna response to pre operative treatment with short term denosumab
work_keys_str_mv AT mccarthyc giantcelltumourofthedistalradiusulnaresponsetopreoperativetreatmentwithshorttermdenosumab
AT gibbonsc giantcelltumourofthedistalradiusulnaresponsetopreoperativetreatmentwithshorttermdenosumab
AT bradleyk giantcelltumourofthedistalradiusulnaresponsetopreoperativetreatmentwithshorttermdenosumab
AT hassana giantcelltumourofthedistalradiusulnaresponsetopreoperativetreatmentwithshorttermdenosumab
AT gieleh giantcelltumourofthedistalradiusulnaresponsetopreoperativetreatmentwithshorttermdenosumab
AT athanasoun giantcelltumourofthedistalradiusulnaresponsetopreoperativetreatmentwithshorttermdenosumab